Future considerations and treatment directions in systemic sclerosis per Dr Steen. #RWCS2022 @RWCSmtg https://t.co/FaJaJ9G5lU

Stem cell transplant has clear benefits on survival and skin thickening. #RWCS2022 @RWCSmtg https://t.co/UnGxLQzy0Q

GAVE - gastric antral vascular ectasia. AKA "watermelon stomach". Is pretty rare https://t.co/DcU0J2TNrN

Dr Steen's recipe to freaking with digital ulcers.#RWCS2022 @RWCSmtg https://t.co/VmDag701JC

Subsets of scleroderma defined by autoantibodies. #RWCS2022 @RWCSmtg https://t.co/ywe0yrHmWd

Many failed clinical trials in Scleroderma in the past. #RWCS2022 @RWCSmtg https://t.co/2PBfHAnqWu

Predicting Treatment Response in Inflammatory Muscle Disorders Rheums looking for clues to whether their patients w/certain inflammatory myopathies will improve on immunosuppressive drugs may find them in a new study in Arthritis Care & Research. https://t.co/kXFIEMTbkb https://t.co/UbO7nSsdAY

• https://bit.ly/3s0cVpX

Significant mortality risk with scleroderma renal crisis. #RWCS2022 @RWCSmtg https://t.co/vIm0xDEjB3

Scleroderma ANA associations thru the ages. Dr. Virginia Steen @RWCSmtg #RWCS2022 https://t.co/U64gpnCgS8

Would combination biologics work? Maybe according to this collection of antecdotal use. #RWCS2022 @RWCSmtg https://t.co/VJdINyqLQt

NOR-DRUM study shows that TDM, therapeutic drug monitoring, is beneficial. Study of RA, PSA, AS, Crohn's, UC Rheums don't do this, should they? #RWCS2022 @RWCSmtg https://t.co/Dc6mgr5jrL

IMPACT2 shows what we see in most PSA trials- little x-ray progression. #RWCS2022 @RWCSmtg https://t.co/uYXHB0s8g0

Dr Artie Kavanaugh presents comparison of targeted therapies in different inflammatory disorders. #RWCS2022 @RWCSmtg https://t.co/cX00RUOgAq

Fecal transplant (FMT) failed to help #PsA, small trial, unexpected result. #RWCS2022 @RWCSmtg https://t.co/zKq6FONuwk

Proposed new pathways involving the inhibition or deletion of kindlin-2, Stat3 and Runx2 in articular chondrocytes that promotes cartilage degradation and osteoarthritis -- potential new therapeutic target for OA https://t.co/EFgGctoYJY

• https://go.nature.com/3rUlKl9